Vivozon Healthcare Inc Cash Flow Conversion Efficiency

Latest as of June 2026: -0.011x

Vivozon Healthcare Inc cash flow conversion efficiency. Based on the latest financial reports, Vivozon Healthcare Inc (082800) has a cash flow conversion efficiency ratio of -0.011x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.10 Billion ≈ $-742.54K USD) by net assets (₩95.30 Billion ≈ $64.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Vivozon Healthcare Inc (2014–2025)

Cash flow conversion efficiency of Vivozon Healthcare Inc from 2014 to 2025. This chart illustrates how Vivozon Healthcare Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Vivozon Healthcare Inc stock quote for real-time trading data and today's change.

Vivozon Healthcare Inc Cash Flow Conversion Ratio Explained

Vivozon Healthcare Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Vivozon Healthcare Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vivozon Healthcare Inc ranked by their cash flow conversion efficiency. Also see 082800 company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Wintec Co. Ltd KQ:320000	-0.043x
Foraco International SA TO:FAR	-0.094x
Som Distilleries & Breweries Limited NSE:SDBL	0.110x
5paisa Capital Ltd NSE:5PAISA	-0.098x
Anderson Industrial Corp TW:1528	0.021x
Northern Minerals Ltd AU:NTU	-6.457x
Arman Financial Services Limited NSE:ARMANFIN	0.087x
EGH Acquisition Corp. Class A Ordinary Shares NASDAQ:EGHA	-0.002x

Annual Cash Flow Conversion Efficiency for Vivozon Healthcare Inc (2014–2025)

The table below shows the annual cash flow conversion efficiency of Vivozon Healthcare Inc from 2014 to 2025. Review Vivozon Healthcare Inc free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩72.66 Billion ≈ $49.24 Million	₩-6.87 Billion ≈ $-4.65 Million	-0.095x	-275.53%
2024-12-31	₩106.43 Billion ≈ $72.12 Million	₩5.73 Billion ≈ $3.88 Million	0.054x	+87.33%
2023-12-31	₩104.07 Billion ≈ $70.52 Million	₩2.99 Billion ≈ $2.03 Million	0.029x	+191.55%
2022-12-31	₩105.84 Billion ≈ $71.72 Million	₩-3.32 Billion ≈ $-2.25 Million	-0.031x	+84.72%
2021-12-31	₩85.12 Billion ≈ $57.68 Million	₩-17.50 Billion ≈ $-11.86 Million	-0.206x	-579.12%
2020-12-31	₩107.80 Billion ≈ $73.06 Million	₩4.62 Billion ≈ $3.13 Million	0.043x	+220.09%
2019-12-31	₩109.00 Billion ≈ $73.87 Million	₩-3.89 Billion ≈ $-2.64 Million	-0.036x	+46.71%
2018-12-31	₩68.45 Billion ≈ $46.38 Million	₩-4.59 Billion ≈ $-3.11 Million	-0.067x	+76.48%
2017-12-31	₩16.10 Billion ≈ $10.91 Million	₩-4.59 Billion ≈ $-3.11 Million	-0.285x	-210.44%
2016-12-31	₩22.74 Billion ≈ $15.41 Million	₩5.87 Billion ≈ $3.98 Million	0.258x	+128.52%
2015-12-31	₩24.65 Billion ≈ $16.71 Million	₩2.78 Billion ≈ $1.89 Million	0.113x	+26.48%
2014-12-31	₩33.90 Billion ≈ $22.97 Million	₩3.03 Billion ≈ $2.05 Million	0.089x	--

About Vivozon Healthcare Inc

KQ:082800 Korea Pharmaceuticals

Market Cap

$162.23 Million

₩239.39 Billion KRW

Market Cap Rank

#17179 Global

#683 in Korea

Share Price

₩3215.00

Change (1 day)

+3.88%

52-Week Range

₩2155.00 - ₩5750.00

All Time High

₩16500.00